Twitxy Saved

Alina Allen

@AlinaAllenMD

#MASLD researcher| Director SLD Clinic @MayoClinic| #biomarkers #datascience #WomenInMedicine| Living life intentionally| Motherhood is my biggest win in life
Mayo Clinic, Rochester MN mayocl.in/3ILw7hj Joined October 2017
842 Following 2K Followers 1.9K Posts

Latest posts 5

Alina Allen @AlinaAllenMD
Looking forward to great science at #TLM26 (thank you for the surprise highlight, AASLD).

@AASLDtweets and @AASLDPresident made a stellar program you don’t want to miss!
#livertwitter #liverX #MASLD
AASLD Verified account @AASLDtweets Sep 3
Meet Dr. Alina M. Allen, a leading voice in the future of MASLD/MASH research! Swipe to learn more about her groundbreaking work and see the #TLM26 sessions where you can hear her insights firsthand.

👉 Learn more about Dr. Allen's sessions here: bit.ly/4qK3I1K

#AASLD #Hepatology #MASLD
View quoted post on X
0 replies 2 reposts 13 likes 1.3K views View on X
Alina Allen @AlinaAllenMD
Thank you for bringing #MASH and #MASLD to the attention of our endocrinology and primary care colleagues, @NeilSkolnik and @AmDiabetesAssn.
ADA Professional Publications Verified account @ADA_Pubs Dec 15, 2025
🚨 NEW special Diabetes Core Update #podcast

In part 2 of series of a series on Metabolic Dysfunction-Associated Steatohepatitis (MASH), host @NeilSkolnik dives into diagnosis and treatment w/ @AlinaAllenMD.

👂 Listen now at: diabetesjournals.org/journals/pages…

This special edition of Diabetes Core Update is sponsored by @Boehringer.

@Diabetes_ADA @DiabetesCareADA @AmDiabetesAssn @ADA_DiabetesPro
View quoted post on X
Alina Allen @AlinaAllenMD
This will be a great opportunity to ask questions about #MASH treatment. Join us!
@RobertFontanaMD @NASH_and_coffee
AASLD Verified account @AASLDtweets Dec 15, 2025
📣 Join us tomorrow!
Don’t miss “Resmetirom and Semaglutide for MASH in 2025: Updated Recommendations from AASLD Guidance” — a live webinar covering the latest in MASLD/MASH management, including current and emerging therapeutic options.

🗓 Tomorrow — Tuesday, December 16, 2025
🕛 12:00 noon EST
🎙 Moderator & Panelists:
Robert Fontana, MD, FAASLD • Alina Allen, MD • Jessica Bartholomew, NP •
Yaron Rotman, MD, MSc, FAASLD • Meena Bansal, MD, FAASLD
💡 Earn AMA PRA Category 1 Credit™

👉 Register now: aasld.org/resmetirom-and…
View quoted post on X
Alina Allen @AlinaAllenMD
I hope the medical community and the general public grasp the results of this study. Best RCT I have seen in a while. Kudos to the research team!! 👏
Exercise is medicine.
Dr Amol Akhade Verified account @SuyogCancer Jun 1, 2025
What if this was a drug ?🙂

🆕 NEJM | June 2025
🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer
📦 RCT | n=889 | Median FU: 7.9 yrs
🟠 3-yr structured aerobic program vs health ed alone
📈 Primary Endpoint: Disease-Free Survival (DFS)
🔹 HR 0.72 (95% CI: 0.55–0.94), p=0.02
🔹 5-yr DFS: 80.3% vs 73.9% (+6.4%)
🟨 Overall Survival (OS)
🔸 HR 0.63 (95% CI: 0.43–0.94)
🔸 8-yr OS: 90.3% vs 83.2% (+7.1%)
🧠 Other highlights:
🔻 ↓ Liver recurrence: 3.6% vs 6.5%
🔻 ↓ New primary cancers: 5.2% vs 9.7%
🔻 Improved cardiorespiratory fitness, QoL, 6-min walk
⚠️ AEs: ↑ MSK issues (18.5% vs 11.5%), mostly mild
No major safety concerns
🤔 What if this was a drug?
📢 “Breakthrough”
💰 $120K/year
📄 Fast-track approval
Instead, it’s just structured EXERCISE.
💡 Prescribe it like we would any other adjuvant therapy.
Congratulations to Authors and Dr Chris Booth 👏
#CHALLENGEtrial #ASCO25 @csoncol @oncology_bg @ASCO #ASCO25 @OncoAlert
View quoted post on X